Unexplained weight loss (UWL), clinically defined as a loss of 5% or more of body weight within a six to twelve-month period, is a challenging diagnostic puzzle. It often indicates serious underlying pathology and necessitates a thorough and systematic approach for accurate diagnosis.
UWL can be attributed to a myriad of causes, most commonly malignancies, gastrointestinal disorders, endocrine diseases, and psychiatric illnesses. Understanding the pathophysiology of these conditions is crucial in formulating a comprehensive diagnostic plan.
A patient-centric, systematic approach is recommended for diagnosing UWL. A detailed history, physical examination, and basic laboratory tests form the cornerstone of this approach. Special attention should be given to age, associated symptoms, and risk factors. In older patients, malignancies and chronic diseases are more prevalent, while in younger patients, psychiatric disorders and malabsorption syndromes should be considered.
While routine imaging is not recommended, it may be warranted in certain cases. For instance, if the clinical history and physical examination suggest a specific organ involvement, targeted imaging can be beneficial. Similarly, in patients with significant weight loss and no clear diagnosis after initial evaluation, computed tomography (CT) of the chest, abdomen, and pelvis may be considered.
Follow-up is crucial in cases of UWL. If initial investigations are inconclusive, patients should be closely monitored for the emergence of new symptoms. This allows for timely intervention and improved patient outcomes.
Diagnosing UWL requires a comprehensive, systematic, and patient-centric approach. Understanding the etiology, adopting an appropriate diagnostic approach, recognizing the role of imaging, and emphasizing the importance of follow-up are all integral to successfully deciphering this enigma. By doing so, clinicians can ensure timely and appropriate management, ultimately improving patient outcomes.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation